GH Secretagogue Peptides
Tesamorelin
C₂₂₁H₃₆₆N₇₂O₆₇S
Key Research Findings
- Characterisation of the trans-3-hexenoic acid N-terminal modification.
- Published pituitary cell-line studies on GH-secretion-pathway activity.
- Pharmacokinetic profile reported in animal-model studies.
Overview
Tesamorelin is a synthetic 44-residue analogue of GHRH with an N-terminal trans-3-hexenoic acid modification. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro studies as a GHRH-receptor ligand active on pituitary somatotroph cell-line assays. Not intended for human or veterinary use.
Research Effects
GHRH-Receptor Binding
Extensive ResearchReported in receptor-binding assays as a high-affinity ligand of the pituitary GHRH receptor.
Somatotroph Cell Assays
Extensive ResearchPublished in-vitro studies in pituitary cell models report effects on GH-secretion-pathway activity.
Stability Profile
Moderate ResearchN-terminal modification characterised in published studies as conferring improved plasma stability.
Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Related Peptides
GH Secretagogue Peptides
CJC-1295 (No DAC)
CJC-1295 (No DAC) is a synthetic 29-residue analogue of growth-hormone-releasing hormone (GHRH), without the Drug Affinity Complex linker. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
GH Secretagogue Peptides
Ipamorelin
Ipamorelin is a synthetic pentapeptide ghrelin-receptor (GHSR-1a) agonist. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
GH Secretagogue Peptides
GHRP-6
GHRP-6 is a synthetic hexapeptide ghrelin-receptor (GHSR-1a) agonist of the first-generation GHRP class. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →